NanoSphere Health Sciences Inc.
NanoSphere Health Sciences Inc.
Your view on NSHSF
Overview
What the company does, where it operates, and who runs it.
About NanoSphere Health Sciences Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Michael Alexander Iverson
- Headquarters
- 1090 West Georgia Street, Vancouver, BC, CA
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Michael Alexander Iverson
- Headquarters
- 1090 West Georgia Street, Vancouver, BC, CA
NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.
It offers NanoSphere Deliver System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for NanoSphere Health Sciences Inc., and the rating behind it. NSHSF last traded at $0.01; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for NanoSphere Health Sciences Inc.. Starting points for NanoSphere Health Sciences Inc.: EPS -$0.0081, beta 0.77 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for NanoSphere Health Sciences Inc.. NanoSphere Health Sciences Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for NanoSphere Health Sciences Inc.. Trailing twelve-month EPS for NanoSphere Health Sciences Inc. stands at -$0.0081. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for NanoSphere Health Sciences Inc.. NanoSphere Health Sciences Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
NanoSphere Health Sciences Inc. valued side by side against its closest peers. NanoSphere Health Sciences Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold NanoSphere Health Sciences Inc., and how their positions are changing. At a $102,752 market value, institutional positions materially move NanoSphere Health Sciences Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by NanoSphere Health Sciences Inc. executives and directors. Shares of NanoSphere Health Sciences Inc. have traded between $0.0038 and $0.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming NanoSphere Health Sciences Inc.. NanoSphere Health Sciences Inc. is a $102,752 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming NanoSphere Health Sciences Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for NanoSphere Health Sciences Inc.. Coverage tracks NanoSphere Health Sciences Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.